Back
Millicom International Cellular SA 10K Form
Buy
76
TIGO
Millicom International Cellular SA
Last Price:
$51.87
Seasonality Move:
3.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TIGO News And Ratings
See the #1 stock for the next 7 days that we like better than TIGO
TIGO Financial Statistics
Sales & Book Value
| Annual Sales: | $5.8B |
|---|---|
| Cash Flow: | $299M |
| Price / Cash Flow: | 9.03 |
| Annual Sales: | $20.01 |
| Price / Book: | 2.59 |
Profitability
| EPS (TTM): | 6.51060 |
|---|---|
| Net Income (TTM): | $1.1B |
| Gross Margin: | $2.6B |
| Return on Equity: | 32.9% |
| Return on Assets: | 7.97% |
Millicom International Cellular SA Earnings Forecast
Key Millicom International Cellular SA Financial Ratios
-
The Gross Profit Margin over the past 32 years for TIGO is 44.73%.
-
The Selling, General & Administrative Expenses for TIGO have been equal to 23.47% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 264.58% of Operating Income.
-
The Net Earning history of TIGO is 4.67% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 14 years.
Millicom International Cellular SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Wireless Telecommunication Services |
| Sector: | Communication Services |
| Current Symbol: | TIGO |
| CUSIP: | L6388F |
| Website: | millicom.com |
Debt
| Debt-to-Equity Ratio: | 2.53 |
|---|---|
| Current Ratio: | 0.92 |
| Quick Ratio: | 0.68 |
Price-to-Earnings
| Trailing P/E Ratio: | 35.38 |
|---|---|
| Forward P/E Ratio: | 12.99 |
TIGO Technical Analysis vs Fundamental Analysis
Buy
76
Millicom International Cellular SA (TIGO)
is a Buy
Is Millicom International Cellular SA a Buy or a Sell?
-
Millicom International Cellular SA stock is rated a BuyThe current Millicom International Cellular SA [TIGO] share price is $51.88. The Score for TIGO is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.